How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review
Autor: | Andrew J. Palmer, Lei Si, William H. Herman, Philip Clarke, Thomas Lung, Xinyang Hua |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Blood Glucose
medicine.medical_specialty United Kingdom Prospective Diabetes Study Cost-Benefit Analysis Type 2 diabetes 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine Linear regression medicine Humans Hypoglycemic Agents Computer Simulation 030212 general & internal medicine Pharmacology Glycated Hemoglobin business.industry 030503 health policy & services Health Policy Public Health Environmental and Occupational Health Type 2 Diabetes Mellitus Cost-effectiveness analysis medicine.disease Confidence interval 3. Good health Quality-adjusted life year Endocrinology Models Economic Diabetes Mellitus Type 2 Cohort Linear Models Systematic Review Quality-Adjusted Life Years 0305 other medical science business Demography |
Zdroj: | Pharmacoeconomics |
ISSN: | 1179-2027 1170-7690 |
Popis: | Background There are an increasing number of studies using simulation models to conduct cost-effectiveness analyses for type 2 diabetes mellitus. Objective To evaluate the relationship between improvements in glycosylated haemoglobin (HbA1c) and simulated health outcomes in type 2 diabetes cost-effectiveness studies. Methods A systematic review was conducted on MEDLINE and EMBASE to collect cost-effectiveness studies using type 2 diabetes simulation models that reported modelled health outcomes of blood glucose-related interventions in terms of quality-adjusted life-years (QALYs) or life expectancy (LE). The data extracted included information used to characterise the study cohort, the intervention’s treatment effects on risk factors and model outcomes. Linear regressions were used to test the relationship between the difference in HbA1c (∆HbA1c) and incremental QALYs (∆QALYs) or LE (∆LE) of intervention and control groups. The ratio between the ∆QALYs and ∆LE was calculated and a scatterplot between the ratio and ∆HbA1c was used to explore the relationship between these two. Results Seventy-six studies were included in this research, contributing to 124 pair of comparators. The pooled regressions indicated that the marginal effect of a 1% HbA1c decrease in intervention resulted in an increase in life-time QALYs and LE of 0.371 (95% confidence interval 0.286–0.456) and 0.642 (95% CI 0.494–0.790), respectively. No evidence of heterogeneity between models was found. An inverse exponential relationship was found and fitted between the ratio (∆QALY/∆LE) and ∆HbA1c. Conclusion There is a consistent relationship between ∆HbA1c and ∆QALYs or ∆LE in cost-effectiveness analyses using type 2 diabetes simulation models. This relationship can be used as a diagnostic tool for decision makers. Electronic supplementary material The online version of this article (doi:10.1007/s40273-016-0466-0) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |